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A murine model was used to characterize the local immune and inflammatory response during ocular
toxoplasmosis. Major histocompatibility complex (MHC) class I, normally expressed at low levels in immune-
privileged sites such as the eye, was up-regulated during infection as determined by competitive reverse
transcriptase (RT)-PCR and immunocytochemistry for both b2-microglobulin and the MHC class I heavy
chain. However, the eyes of chronically infected mice also had increased levels of mRNA transcripts for
transforming growth factor b, a cytokine associated with immune privilege and constitutively expressed in
normal eyes. Transcripts for a number of inflammatory mediators, including interleukin-6 (IL-6), were
increased during chronic infection. The role of IL-6 was further investigated by comparing disease progression
and the development of the local immune response in wild-type (WT) and IL-6-deficient mice (IL-62/2 mice).
Following infection, IL-62/2 mice developed more severe inflammation in the retina and vitreous humor
compared with WT mice. This increased severity of disease was associated with reduced ocular IL-1a and
increased tumor necrosis factor a mRNA production compared with WT mice. Moreover, the increased severity
of disease in IL-62/2 mice correlated with increased eye parasite burden as determined by RT-PCR for the
Toxoplasma gondii bradyzoite-specific LDH2 gene. These results demonstrate alterations to components of
immune privilege as a result of ocular toxoplasmosis and a role for IL-6 in controlling parasite numbers and
inflammation in the eye.
Ocular toxoplasmosis (OT) is associated with inflammation
of the retina and uveal tract. It is a recurring and progressive
disease that can result in destruction of the retina and loss of
sight (6). The relative contribution of the host inflammatory
response versus parasite proliferation in causing destruction of
the retina has not been defined (29). The eye is an immune-
privileged site and inflammatory products such as tumor ne-
crosis factor a (TNF-a), gamma interferon (IFN-g), and nitric
oxide production have been linked to experimental autoim-
mune uveitis (25, 39). Under normal circumstances, the eye
constitutively expresses transforming growth factor b (TGF-b)
and has low levels of major histocompatibility complex (MHC)
class I expression in order to down-regulate inflammatory me-
diators and the immune response (33). In addition, high con-
stitutive expression of Fas ligand on ocular cells would serve to
induce apoptosis and down-regulate the function of T cells and
NK cells (33, 34). Together these factors would generally serve
to prevent damage or destruction of the eye as a result of
inflammation. However, these anti-inflammatory processes
may also contribute to an immunological environment that is
conducive to the survival and multiplication of Toxoplasma
gondii. For example, not only can TGF-b down-regulate the
ability of NK cells to respond to T. gondii products (15), but
also TGF-b can antagonize the activation of macrophages by
reducing their ability to produce nitric oxide, which is an im-
portant anti-T. gondii effector mechanism in murine and hu-
man cells (13). In addition, TGF-b can prevent the induction
of the tryptophan-degrading enzyme indolamine, which has
been shown to prevent parasite multiplication in human cells
(21). Furthermore, the relatively low expression of MHC class
I molecules in the eye (34) would serve to reduce the potential
activities of anti-T. gondii cytolytic CD81 T cells, which are
known to play a significant role in killing T. gondii-infected
cells (7, 10, 24). Immunological control of T. gondii in the eye
is therefore complex, because many of the mechanisms re-
quired to control parasite numbers may also adversely influ-
ence immune privilege and cause tissue damage.
The present study was undertaken to characterize further
the immune response during OT. To achieve this we employed
a combination of competitive reverse transcription-PCR (cRT-
PCR) and immunocytochemistry (ICC). Although it cannot be
assumed that the mRNA levels measured through cRT-PCR
correlate absolutely with protein production, many studies
have found cRT-PCR to be a useful method for evaluating
ongoing immune responses. Infection was found to signifi-
cantly alter the expression of immune system components as-
sociated with immune privilege in the eye; i.e., there was in-
creased expression of b2-microglobulin and TGF-b. As
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previously described, infection was found to induce or increase
levels of mRNA transcripts for a number of inflammatory
mediators, including TNF-a and inducible nitric oxide synthase
(iNOS), in ocular tissue. Both of these mediators are known to
have a protective role for the host during OT (9, 14, 30).
Previous studies have found that infection of human retinal
pigment epithelial (HRPE) cells with T. gondii induces inter-
leukin-6 (IL-6) (22). Accordingly, we also found transcripts for
IL-6 in the eyes of mice infected with T. gondii. The role of
IL-6 was therefore investigated by comparing disease progres-
sion and the development of the local immune response in
wild-type (WT) and IL-6-deficient (IL-62/2) mice. Following
infection with T. gondii, IL-62/2 mice developed more severe
inflammation in their retinas, vitreous humor, and uveas than
did WT mice. The increased severity of disease in IL-62/2 mice
compared with WT mice was associated with increased num-
bers of parasites.
MATERIALS AND METHODS
Mice and T. gondii infections. Female mice of the 129/SVJ strain (WT) and
IL-62/2 mice of the same genetic background, as previously described (17), were
bred and maintained at the University of Strathclyde. Mice were infected with 10
T. gondii tissue cysts (Beverley strain) by the intraperitoneal route at 4 to 6 weeks
of age, as previously described (28). Four weeks after infection, eyes were
removed from both infected and age-matched uninfected control animals for
histopathological examination, ICC, or RNA extraction. This time point was
chosen because preliminary studies found that OT was not clearly evident at 3
weeks postinfection, and it was also chosen to precede the mortality evident after
4 weeks postinfection.
Tissue processing and histopathology. Eyes were fixed in 0.1 M phosphate
buffer (pH 7.4) containing 4% formaldehyde. Sections were cut from paraffin-
embedded tissues and stained with hematoxylin and eosin stain. All sections were
examined and assessed without knowledge of the group from which they origi-
nated. The number of inflammatory cells in the vitreous humor, retina, and
choroid were graded from 1 to 3 as follows: 1, mild (less than 10 inflammatory
cells per field at 3400 magnification); 2, moderate (between 11 and 20 inflam-
matory cells per field at 3400 magnification); and 3, severe (between 21 and 30
inflammatory cells per field at 3400 magnification). The score at each site was
compared using the Mann-Whitney U test. In addition, the cysts in three con-
secutive sections were counted.
Immunocytochemistry. Sections of the eyes processed for histology were de-
waxed, and the endogenous peroxidase was blocked prior to pressure cooking for
90 s. Serial sections were then blocked with 1% bovine serum albumin in Tris
buffer and incubated with either goat anti-b2-microglobulin (Santa Cruz Bio-
technology, Inc.), mouse anti-BAG1 (bradyzoite specific antibody [4a]) or fluo-
rescein isothiocyanate-conjugated mouse anti-mouse H-2Db clone no. KH95
(Pharmingen, Oxford, United Kingdom) in Tris buffer. After washing, sections
were stained with the appropriate second antibody conjugated to peroxidase, and
the reaction product was developed using diaminobenzidine and hydrogen per-
oxide as a chromogen. Alternatively, sections stained for H-2Db were examined
by fluorescence microscopy. Slides were counterstained with hematoxylin prior
to examination. To identify any possible quantitative difference, sections of the
eyes from infected and uninfected controls of both WT and IL-62/2 mice were
stained in parallel using identical reagents and incubation times.
RNA extraction. Four weeks after infection, eyes from infected or uninfected
control SVJ or IL-62/2 mice were carefully removed and homogenized in 1 ml
of TRIzol reagent (Gibco BRL Life Technologies, Paisley, United Kingdom).
Total RNA was isolated following a protocol based on the single-step acid
guanidinium thiocyanate-phenol-chloroform RNA isolation method (8).
Reverse transcription. cDNA was produced from total RNA using Moloney
murine leukemia virus RT (Gibco BRL Life Technologies) according to the
manufacturer’s specifications. In a 90-ml reaction volume, 7 mg of RNA was
combined with 18 ml of 53 first-strand buffer (250 mM Tris-HCl [pH 8.3], 375
mM KCl, and 15 mM MgCl2)–18 ml of deoxynucleoside triphosphate (dNTP)
mix (10 mM)–9 ml of 0.1 M dithiothreitol–80 U of RNasin ribonuclease inhibitor
(Promega)–500 ng of random hexamer primers (Promega)–1,200 U of Moloney
murine leukemia virus RT. Following a 10-min preincubation at 27°C, the mix-
ture was incubated at 42°C for 60 min, and then the reaction was terminated by
heating at 95°C for 5 min. All cDNA was stored at 220°C until used in PCR.
cRT-PCR for cytokine transcripts. The level of cytokine transcripts was as-
sessed by cRT-PCR as described previously (5, 11, 30) using multispecific com-
petitor plasmids pMUS (32), pNIL (18), and pQRS (27). cRT-PCR is a flexible
system that easily assesses differences in multiple immune mediators even in
small amounts of nonlymphoid tissue such as the eye. Although it cannot be
assumed that mRNA levels measured through cRT-PCR correlate absolutely
with protein production, many studies have found this to be a useful method to
evaluate ongoing immune responses (5, 11, 18, 27, 30, 32). To ensure that equal
quantities of cDNA were used in PCR for each sample, levels of transcript were
first normalized against hypoxanthine-guanosine phosphoribosyl transferase
(HPRT). To achieve this, PCR was first performed for HPRT in the absence of
competitor (pQRS), and samples were adjusted until similar band intensities
were observed. To confirm normalization, PCR for HPRT was then performed
in the presence of a constant amount of competitor. Where necessary, samples
were adjusted until the resulting amplification resulted in equal intensities of
specific and competitor products for all of the samples (30). All PCR mixtures
were made to 25 ml and contained a final concentration of 13 PCR buffer (50
mM KCl, 10 mM Tris-HCl [pH 9.0], and 0.1% Triton X-100)–1.5 mM MgCl2–
200 mM for each dNTP–0.5 mM for each primer–0.25 U of Taq DNA polymerase
(Promega). Cycling conditions included an initial denaturation at 94°C for 3 min
followed by 35 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 1 min.
Reactions were finished with a final extension period for 10 min at 72°C. Primers
utilized in these experiments are as follows: HPRT forward and reverse primers
(59-GGATTTGAAATTCCAGAG-39 and 59-GAGGGTAGGCTGGCCTATG
GCT-39, respectively) for use with pQRS; b2-microglobulin forward and reverse
primers (59-TGACCGGCTTGTATGCTATC-39 and 59-CAGTGTGAGCCAG
GATATAG-39) for pMUS; TGF-b forward and reverse primers (59-ACCGCA
ACAACGCCATCTAT-39 and 59-GTAACGCCAGGAATTGTTGC-39) for
pMUS; IL-1a forward and reverse primers (59-CAGTTCTGCCATTGACCAT
C-39 and 59-TCTCACTGAAACTCAGCCGT-39) for pMUS; TNF-a forward
and reverse primers (59-TCTCATCAGTTCTATGGCCC-39 and 59-GGGAGT
AGACAAGGTACAAC-39) for pMUS; IL-6 forward and reverse primers (59-
GTTCTCTGGGAAATCGTGGA-39 and 59-TGTACTCCAGGTAGCTATGG-
39) for pMUS; and iNOS forward and reverse primers (59-AGCTCCTCCCAG
GACCACAC-39 and 59-ACGCTGAGTACCTCATTGGC-39) for use with
pNIL. IFN-g forward and reverse primers (59-GCTCTGAGACAATGAACGC
T-39 and 59-AAAGAGATAATCTGGCTCTGC-39) and IL-10 forward and re-
verse primers (59-AGCCGGGAAGACAATAACTG-39 and 59-CATTTCCGAT
AAGGCTTGG-39) were also used in the absence of competitor. The amounts of
specific and competitor product of each reaction were assessed from scanned
images of ethidium bromide-stained gels using NIH Image. The ratios of the
total volume (density times area) of competitor to specific products were deter-
mined, and statistical analyses were performed using the Mann-Whitney U test.
Detection of parasites by RT-PCR. To increase sensitivity for the detection of
parasite-specific transcripts in the eyes of infected mice, a modified PCR fol-
lowed by enhanced chemiluminescence (ECL) was performed. RT-PCR was
performed as outlined above using biotin-labeled primers specific to the brady-
zoite stage (LDH2) or the tachyzoite stage (SAG2). Primers utilized were
LDH2for (59-ATGACGGGTACCGTTAGC-39), LDH2rev (59-GCTCGCTTCA
TGAAAGCA-39), SAG2for (59-TGATGCATGCTCCAGTGGTTC-39), and
SAG2rev (59-ACAAGCATGCGAGACCGG-39). Following electrophoresis, the
PCR products were transferred onto a Hybond-N1 nylon membrane (Amersham
Pharmacia Biotech) by capillary transfer, as described by Sambrook et al. (31).
Following heat fixation, the membrane was blocked overnight and incubated at
room temperature in a 1:32,000 dilution of streptavidin-horseradish peroxidase
(Amersham Pharmacia Biotech) for 1 h. After washing, the membrane was
flooded with ECL detection reagent (Amersham Pharmacia Biotech) and ex-
posed to film.
RESULTS
Cytokine expression in the eyes of infected WT mice. Pre-
liminary investigation of mRNA expression for selected cyto-
kines in the eyes of WT mice infected with T. gondii was carried
out. Samples were normalized against HPRT in the presence
of pQRS as described in Materials and Methods. Similar in-
tensities of the lower bands (specific product) and the corre-
sponding upper bands (competitor product) indicated that all
samples were normalized relative to the competitor and each
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other. For all subsequent PCRs, sample volumes remained
unchanged.
To investigate the effect of infection on immune privilege in
the eye, PCR was next carried out for b2-microglobulin and
TGF-b. Transcripts for both of these molecules were present
in the eyes of normal control mice. Following infection, an
increase in the level of transcript for b2-microglobulin in the
eyes of infected mice was demonstrated by an increase in the
intensity of specific product relative to the pMUS competitor
construct. TGF-b transcript was also increased in the eyes of T.
gondii-infected mice. IL-6 transcript was absent from the eyes
of normal control mice, but it was present in the eyes of all
infected mice. These results are not shown, because these
results are also evident in subsequent experiments that com-
pare WT and IL-62/2 mice (Fig. 1a).
Comparison of ocular pathology in infected WT and IL-62/2
mice. The relevance of our preliminary finding that IL-6 tran-
scripts are present in the eyes of mice infected with T. gondii
was tested by comparing the severity of OT in WT and IL-62/2
mice. The eyes of both WT and IL-62/2 mice infected with T.
gondii had inflammation in their retinas, vitreous humor, and
choroid (Table 1). Inflammatory cells were also present within
the ciliary body and anterior chamber. Retinal inflammation
was most marked in the inner retinal layers. When the inflam-
mation in each site was compared using the Mann-Whitney U
test, the score for inflammation in the retina and vitreous
humor in IL-62/2 mice was significantly greater than in WT
mice (retina, P 5 0.027; vitreous humor, P 5 0.026). Similar
results were obtained in four experiments using male or female
mice. Female mice generally had more severe inflammation
than male mice (results not shown). In some of the eyes from
IL-62/2 mice, there were clusters of several cysts. Although
there were no significant differences in the overall cyst bur-
dens, IL-62/2 mice generally had increased numbers of cysts in
FIG. 1. The effect of T. gondii infection on intraocular expression of b2-microglobulin, TGF-b, IL-1a, TNF-a, IL-6, and iNOS, as measured
by cRT-PCR. (a) Samples were first normalized for HPRT expression (note similar intensities of upper band [competitor product] with lower band
[specific product]). The quantity of sample used to achieve this normalization was used in subsequent PCR. b2-Microglobulin expression was
increased in infected mice compared with uninfected control mice (note increased intensities of lower band [specific product] compared with upper
band [competitor product] in infected mice, but equal intensity of both bands in control samples). TGF-b was present in control samples but was
up-regulated during infection (note low levels or absence of lower band [specific product] in control samples due to competition with competitor
[upper band]). However, in samples from infected mice, both competitor and specific products are present, indicating increased expression. IL-1a
transcripts were absent or present at low levels in control samples (lower band). Expression of IL-1a was increased in WT mice following infection
(note presence of lower band in all samples) but not to the same extent as in IL-62/2 mice (note increased intensity of upper band [competitor
product] in IL-62/2 samples compared with lower band [specific product]). TNF-a expression was increased in IL-62/2 samples following infection
but not in WT mice (note presence of lower band [specific product] in all samples compared with low intensity or absence in WT samples). IL-6
expression (albeit nonfunctional) was increased in IL-62/2 samples following infection but not in WT mice (note presence of lower band [specific
product] in all samples compared with low intensity or absence in WT samples). Expression of iNOS was low or absent in control mice but increased
during infection (note increased intensity of upper bands [specific product] relative to lower bands [competitor product] in infected mice compared
with control mice). IFN-g and IL-10 transcripts were present in the eyes of both control and infected mice of each strain but at low levels which
precluded comparison using a competitive construct (results not shown). These results are representative of two replicate experiments. (b)
Transcripts for T. gondii LDH2 were absent from control mice but were present at low levels in four of five WT mice and at high levels in four
of five IL-62/2 mice (note artifact in lane 2 for WT mice). These results are representative of two replicate experiments.
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their eyes compared with WT mice, and cysts were often found
in clusters rather than as individual cysts as in the WT mice. T.
gondii tissue cysts stained positive for BAG1 but, as expected,
were negative for b2-microglobulin (Fig. 2A and B). Eyes from
uninfected control mice were normal.
Comparison of cytokine expression and parasite numbers in
the eyes of infected WT and IL-62/2 mice. The ocular immune
response was compared in WT and IL-62/2 mice infected with
T. gondii to determine whether the increased severity in IL-
62/2 mice was due to an increased inflammatory response or to
greater parasite burdens. Samples from eyes of three unin-
fected and five infected mice each for the WT and IL-62/2
strains were again normalized by performing competitive RT-
PCR for HPRT (Fig. 1a).
Significant increases in the transcription of genes encoding
b2-microglobulin (P 5 0.0245), TGF-b (P 5 0.0245), iNOS
(P 5 0.0245), and IL-6 (P 5 0.0245) were observed in infected
WT and IL-62/2 mice (Fig. 1a) (IL-6 transcripts in IL-62/2
mice are nonfunctional). IL-1a transcript was also increased
during T. gondii infection (P 5 0.0245). However, this increase
was greater in WT than in IL-62/2 mice (P 5 0.0163). Con-
versely, although transcripts for TNF-a were expressed in un-
infected control eyes, TNF-a was induced to a greater extent in
IL-62/2 mice than in WT mice (P 5 0.0163) (Fig. 1a). IFN-g
and IL-10 transcripts were present in the eyes of both control
and infected mice of each strain but at low levels which pre-
cluded comparison using a competitive construct (results not
shown).
Finally, we investigated the amount of transcript of brady-
zoite-specific LDH2 gene and tachyzoite-specific SAG2 gene as
a semiquantitative analysis of the number of parasites in the
eyes of infected mice. Sensitivity of the PCR was increased at
least 10-fold by using biotin-labeled primers and subsequent
transfer to a nylon membrane and ECL. Despite this, SAG2
transcript could only be detected in a sample from one mouse,
indicating that very few tachyzoites were present in the eyes of
infected mice (data not shown). LDH2 transcript was observed
in the eyes of both WT and IL-62/2 mice, indicating the pres-
ence of the bradyzoite cyst stages. Levels of LDH2 transcripts
were generally higher in the eyes of infected IL-62/2 mice
compared to WT mice (Fig. 1b) in two experiments (P 5
0.374).
Comparison of staining for b2-microglobulin and MHC
class I heavy chain in the eyes of uninfected and infected WT
and IL-62/2 mice. In the eyes from infected WT and IL-62/2
mice, there was membranous staining for b2-microglobulin in
the ciliary body epithelium (Fig. 2D), ganglion cell layer of the
retina (Fig. 2F), and inflammatory cells within the retina (Fig.
2G). Cytoplasmic staining was also identified in the ciliary body
epithelium and in the retinal pigment epithelium (Fig. 2D and
F). Similar staining was observed for MHC class I (results not
shown). There was no difference in the pattern or intensity of
staining between WT and IL-62/2 mice (data not shown). Eyes
from uninfected control mice were negative for b2-micro-
globulin (Fig. 2E) and MHC class I (results not shown).
DISCUSSION
The pathogenesis of murine OT was investigated. Of partic-
ular interest was the extent to which factors associated with the
immune privilege nature of the eye were compromised. A
hallmark of immune privilege in the eye is constitutive expres-
sion of TGF-b (33). We also found constitutive expression of
TGF-b in the eye, but in addition we found that OT signifi-
cantly increases levels of TGF-b transcripts. While this in-
crease in levels of TGF-b may serve to maintain immune
privilege and to reduce damage due to inflammation, it may
also have beneficial effects on the multiplication and survival of
T. gondii. For example, TGF-b has been shown not only to
reduce the ability of NK cells, a major source of IFN-g, to
respond to T. gondii but also to markedly down-regulate mac-
rophage functions, including their ability to produce nitric ox-
ide and indolamine (13, 15, 21). IFN-g is the major mediator of
resistance against T. gondii, and treatment of a number of
nonphagocytic human cells has been shown to prevent the
multiplication of T. gondii by inducing indolamine, which de-
grades tryptophan and starves the parasite of this amino acid
(26, 36). Following stimulation with IFN-g, nitric oxide has
been shown to mediate killing of T. gondii in a number of
murine and human cell types, and, significantly, nitric oxide has
been shown to play a protective role during murine OT (19).
Low levels of MHC class I expression are another hallmark
of immune privilege in the eye (34). This study found that
MHC class I is up-regulated in the eyes of mice with OT, as
demonstrated by increased levels of b2-microglobulin mRNA
transcripts and up-regulation of cell surface MHC class I. Ex-
pression of MHC class I has been shown to be increased by
IFN-g, and accordingly we did find transcripts for IFN-g in the
eyes of infected but not uninfected mice (3). Up-regulation of
MHC class I in the cells of the eye during infection would
generally facilitate CD81 cytotoxic T lymphocyte (CTL) killing
of T. gondii-infected cells and may serve to limit parasite mul-
tiplication. Notably, CD81 CTLs have been demonstrated in
vitro to lyse T. gondii-infected cells (12, 35). In addition, adop-
tive transfer of CD81 T cells from chronically infected mice to
naı¨ve mice has also been shown to mediate protection against
infection with T. gondii (24). The accentuation of one aspect of
TABLE 1. Comparison of histopathology in the eyes of female WT
and IL-62/2 mice following infection with T. gondiia
Mouse strain
Level of inflammationb by
eye location
No. of cysts
Retina Choroid Vitreoushumor
WT 2 0 1 0
2 1 1 0
1 1 0 1
2 1 1 1
0 1 0 0
IL-62/2 3 0 2 0
3 2 2 5
3 0 2 2
2 1 1 0
a Mice were infected intraperitoneally with 15 cysts of the Beverley strain, and
their eyes were examined histologically 4 weeks after infection. Eyes from IL-
62/2 mice (n 5 4) had significantly increased inflammation in their retinas (P 5
0.027) and vitreous humor (P 5 0.026) compared with WT mice (n 5 5). Similar
results were obtained in four experiments using male or female mice, although
female mice generally had more severe inflammation than male mice.
b 0, none; 1, mild; 2, moderate; 3, severe.
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FIG. 2. Immunohistochemical staining for BAG-1 and b2-microglobulin. (A) Serial section of retina from an infected IL-62/2 mouse showing
positive staining of Toxoplasma cysts for BAG-1 (arrow) (magnification, 3360). (B) Serial section of retina from an infected IL-62/2 mouse
showing positive staining of ganglion cells (g) for b2-microglobulin. Toxoplasma cysts are indicated with an arrow. (C) Ciliary body from an
uninfected WT mouse which shows no immunostaining for b2-microglobulin (magnification, 3250). (D) Ciliary body from an infected WT mouse
showing positive staining of the ciliary body epithelium for b2-microglobulin (magnification, 3225). (E) Retina from uninfected WT mouse which
shows no immunostaining for b2-microglobulin (magnification, 390) (note absence of staining in retinal pigment epithelium [rpe]). (F) Retina
from an infected mouse showing positive staining of the ganglion cells and retinal pigment epithelium for b2-microglobulin (magnification, 390).
(G) Retina from an infected IL-62/2 mouse showing positive staining of inflammatory cells (i) in the inner retinal layers for b2-microglobulin.
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immune privilege, namely TGF-b production, coupled with the
increased expression of MHC class I, which represents an
ablation of immune privilege during OT, requires explanation.
We suggest that the up-regulation of MHC class I may confer
ability in the immune system to efficiently and specifically rec-
ognize and lyse infected cells, while the up-regulation of
TGF-b may protect uninfected cells from nonspecific inflam-
matory responses.
During the course of these studies a number of inflammatory
mediators were up-regulated in the eyes of mice during infec-
tion, including TNF-a, iNOS, IL-1, and IL-6. While TNF-a
and iNOS have previously been shown to be increased and to
play a beneficial role during OT, the roles of IL-1 and IL-6
have not been investigated (9, 14, 30). IL-6 has, however, been
previously detected in the eyes of cats with OT and in the
vitreous humor of infected human eyes (20, 22). Furthermore,
a recent study found that in vitro infection of HRPE cells with
T. gondii induced the transcription of a number of inflamma-
tory mediators, including IL-6 (23). We therefore investigated
the role of IL-6 during OT by comparing disease progression
and the local immune response in WT and IL-62/2 mice.
Following infection with T. gondii, IL-62/2 mice developed a
more severe inflammation in their retina vitreous than WT
mice. Previous studies have provided conflicting data concern-
ing the role of IL-6 during toxoplasmosis. Thus, while in vitro
studies have found that IL-6 inhibits IFN-g-mediated T. gondii
killing (4), further studies suggest that IL-6 may reduce para-
site multiplication by promoting encystment (40). Murine
models of disease again provide conflicting data regarding the
role of IL-6 (16). In support of a disease-promoting role, neu-
tralization of IL-6 has been shown to reduce cyst burdens and
the severity of the inflammatory process in the brains of in-
fected animals (37). In contrast, a host-protective role is sup-
ported by the increased mortality and severity of neurological
disease observed in IL-62/2 mice compared with WT mice
after infection with T. gondii (16). Nevertheless, IL-6 has been
shown to have a role in down-regulating the inflammatory
response by inhibiting the production of IL-1 and TNF-a (1, 2,
38). This would suggest that IL-6 could promote parasite
growth while reducing pathology. Further studies were there-
fore performed to determine whether the increased severity of
ocular inflammation observed in IL-62/2 mice was due to
increased parasite multiplication and associated destruction of
host cells or was a direct consequence of a failure to control
inflammation in the absence of IL-6. In agreement with our
preliminary studies, cRT-PCR revealed that b2-microglobulin
and TGF-b were increased in infected WT and IL-62/2 mice
compared with uninfected controls. The inflammatory media-
tors IL-1a, TNF-a, and iNOS were also up-regulated in the
eyes of both WT and IL-62/2 mice following infection, as were
those of IL-6. Furthermore, IL-62/2 mice had increased levels
of IL-6 transcripts, albeit nonfunctional, compared with WT
mice. This is consistent with previous studies of these mice and
suggests a role for IL-6 in regulation of its transcription (17).
Whereas there was no significant difference in the levels of
iNOS transcript between mouse strains, IL-62/2 mice had re-
duced ocular IL-1a. This finding indicates that the increased
susceptibility of the IL-62/2 mice over WT mice is not due to
reduced nitric oxide production. Consistent with previous stud-
ies, which found that mice deficient in IL-6 produced more
TNF-a in response to lipopolysaccharide challenge than did
WT mice (17) following infection with T. gondii, the eyes of
IL-62/2 mice had increased levels of transcript for TNF-a
compared with WT mice. While previous studies demonstrated
a protective role for TNF-a during OT (9), the IL-62/2 mice
had more severe ocular inflammation despite producing more
TNF-a than WT mice. Furthermore, in a series of experiments,
IL-62/2 mice generally had increased parasite burdens in their
eyes compared with WT mice, as determined by RT-PCR for
the T. gondii bradyzoite-specific LDH2 gene. The inability of
histological examination to detect this difference is undoubt-
edly due to the relative rarity of tissue cysts in the eye and the
fact that this type of analysis examines only a few cross sections
of the eye. In comparison, the RT-PCR method assesses par-
asite number in the entire eye and in this respect provides a
clear advantage over histological examination alone. It is in-
teresting that transcripts for SAG2 were generally not detect-
able in the eyes of either WT or IL-62/2 mice by RT-PCR,
indicating that the form of the parasite present was predomi-
nately the bradyzoite and not the tachyzoite. It is unlikely that
this is a limitation of the method used, because we can detect
as few as 10 tachyzoites in a sample.
Whether the protective role of IL-6 during OT is due to
ocular or systemic immunity remains to be determined. How-
ever, a role for IL-6 in the ocular site is suggested, as tran-
scripts for IL-6 are found only in the eyes of infected mice.
Furthermore, in IL-62/2 mice, IL-1a production is increased
while TNF-a production is decreased compared with that in
WT animals. Significantly, therefore, these studies do demon-
strate that intraocularly produced IL-6 does not have a proin-
flammatory or disease-potentiating effect during OT.
Together these results demonstrate that OT selectively in-
duces changes to immune privilege in the eye that may favor
MHC class I-mediated killing of infected cells while limiting
inflammation by increasing TGF-b production. In addition,
IL-6 plays a beneficial role in limiting parasite burden and
inflammation in the eyes of mice infected with T. gondii.
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